&nbsp;

Drugs Used:

bortezomib (PDRP prior authorization),

lenalidomide,

dexamethasone

Quick Link(s):

Regimen Monograph

Dec 2023

Regimen

CYCLDOCE+PEMB

Cancer Type:

Breast

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

ZOLE

Cancer Type:

Breast

Intent: Adjuvant

Drugs Used:

zoledronic acid

Quick Link(s):

Regimen Monograph

May 2023

Regimen

CETU

Cancer Type:

Head and Neck

Intent: Palliative

Drugs Used:

cetuximab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

CISPFU(RT)

Cancer Type:

Head and Neck

Intent: Palliative, Adjuvant

Drugs Used:

CISplatin,

fluorouracil

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

TOPO

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Drugs Used:

topotecan

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

BORTDEXALENA(LD)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - In Combination with Lenalidomide and Dexamethasone for Previously Untreated Multiple Myeloma Pre-SCT

ODB Limited Use

lenalidomide - Induction therapy for transplant eligible, newly diagnosed multiple myeloma, according to clinical criteria

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2023

Regimen

DEXAPOMA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

Exceptional Access Program

pomalidomide - For patients with relapsed and/or refractory multiple myeloma, according to specific criteria.

ODB - General Benefit

dexamethasone

Drugs Used:

pomalidomide,

dexamethasone

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

CETU

Cancer Type:

Skin,

Squamous Cell

Intent: Palliative

Drugs Used:

cetuximab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

CRBPETOP

Cancer Type:

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Hepatobiliary / Liver / Bile Duct,

Pancreas,

Genitourinary,

Bladder / Urothelial,

Prostate,

Head and Neck,

Lung,

Small Cell

Intent: Adjuvant

Drugs Used:

CARBOplatin,

etoposide

Quick Link(s):

Regimen Monograph

Dec 2023

Regimen

CRBPIRIN

Cancer Type:

Breast,

Central Nervous System,

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Hepatobiliary / Liver / Bile Duct,

Pancreas,

Genitourinary,

Bladder / Urothelial,

Prostate,

Gynecologic,

Cervix,

Endometrial,

Ovary,

Head and Neck,

Lung,

Small Cell

Intent: Adjuvant, Curative, Palliative

Drugs Used:

CARBOplatin,

irinotecan